Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy

This publication has 123 references indexed in Scilit:

• Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
  PLOS ONE, 2013
• Binding Mode of CpG Oligodeoxynucleotides to Nanoparticles Regulates Bifurcated Cytokine induction via Toll-like Receptor 9
  Scientific Reports, 2012
• Nano‐particle vaccination combined with TLR‐7 and ‐9 ligands triggers memory and effector CD8⁺T‐cell responses in melanoma patients
  European Journal of Immunology, 2012
• Targeting pattern recognition receptors in cancer immunotherapy
  Targeted Oncology, 2012
• The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
  Nature Immunology, 2010
• STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
  Nature, 2008
• TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts
  Proceedings of the National Academy of Sciences, 2007
• Ligand-induced conformational changes allosterically activate Toll-like receptor 9
  Nature Immunology, 2007
• Vascular disrupting agents in clinical development
  British Journal of Cancer, 2007
• Toll-like receptors and innate immunity
  Nature Reviews Immunology, 2001